<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT05101720</url>
  </required_header>
  <id_info>
    <org_study_id>CE-AVEC 555/2021/Sper/AOUFe</org_study_id>
    <nct_id>NCT05101720</nct_id>
  </id_info>
  <brief_title>Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation: ZEROFLUOROAXI TRIAL</brief_title>
  <acronym>ZEROFLUOROAXI</acronym>
  <official_title>Ultrasound Guided Axillary Access vs Standard Fluoroscopic Technique for Cardiac Lead Implantation</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital of Ferrara</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital of Ferrara</source>
  <oversight_info>
    <has_dmc>Yes</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      Single center, randomized trial (1:1 fashion) to asses the safety and the feasibility of the&#xD;
      ultrasound guided venous puncture vs standard fluoroscopic technique in patients undergoing&#xD;
      pacemaker or implantable cardioverter-defibrillator implantations.&#xD;
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Rationale: axillary, cephalic and subclavian venous accesses are commonly used in pacemaker&#xD;
      and implantable cardioverter defibrillator implantations. Axillary puncture and cephalic vein&#xD;
      surgical cutdown are both recommended in international guidelines due to low risk of&#xD;
      pneumothorax and chronic lead complications. Sometimes cephalic vein is not available. Today&#xD;
      axillary puncture is performed under fluoroscopic view and some complications still exist&#xD;
      with this venous access as pneumothorax and arterial puncture. Axillary vein direct&#xD;
      visualization can be obtained with standard venography or with ultrasound. With direct&#xD;
      visualization and puncture of the axillary vein under ultrasound guidance venography with&#xD;
      radiocontrast could be avoided. Less radiation exposure for patient and operator and direct&#xD;
      visualization of the needle are possible with lower periprocedural complications using&#xD;
      ultrasound. Despite the great interest for ultrasound guided axillary puncture up today we&#xD;
      have few data on its feasibility. Our hypothesis is that ultrasound guided axillary access is&#xD;
      more safe and more feasible than the standard fluoroscopic technique.&#xD;
&#xD;
      We decided to enroll all the patients undergoing standard transvenous pacemaker or&#xD;
      cardioverter implantable defibrillator. We randomize the patients with 1:1 fashion to&#xD;
      axillary venous access under fluoroscopic guidance or to ultrasound guided axillary venous&#xD;
      access.&#xD;
&#xD;
      Obiectives: to asses safety, feasibility of the ultrasound guided venous puncture.&#xD;
&#xD;
      Main Endpoint: composite of pneumothorax, pocket hematoma, arterial puncture, pocket or&#xD;
      device infection, hemothorax at 30 days.&#xD;
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">October 25, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2022</completion_date>
  <primary_completion_date type="Anticipated">November 30, 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Outcomes Assessor)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Composite of pneumothorax, pocket hematoma, arterial puncture, pocket or device infection, hemothorax at 30 days.</measure>
    <time_frame>One month after index procedure</time_frame>
    <description>Composite of pneumothorax, pocket hematoma, arterial puncture, pocket or device infection, hemothorax at 30 days.</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">280</enrollment>
  <condition>Arrhythmias, Cardiac</condition>
  <condition>Venous Puncture</condition>
  <condition>Implantable Defibrillator User</condition>
  <condition>Pacemaker Complication</condition>
  <condition>Vascular Access Complication</condition>
  <condition>Fluoroscopy; Adverse Effect</condition>
  <arm_group>
    <arm_group_label>Ultrasound Guided Axillary Access</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Direct visualization of axillary vein with ultrasound will be obtained and used as a guidance for venous puncture.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Fluoroscopic Guided Axillary Access</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Standard technique: using the intersection of the lateral borders of the second and third rib as a radiological landmarks.</description>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Ultrasound Guided Axillary Venous Access</intervention_name>
    <description>Direct visualization of axillary vein will be obtained with ultrasound sterile linear probe.</description>
    <arm_group_label>Ultrasound Guided Axillary Access</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Fluoroscopy-Guided Axillary Venous Access</intervention_name>
    <description>Fluoroscopic landmarks will be used and axillary venous puncture will be performed without ultrasound</description>
    <arm_group_label>Fluoroscopic Guided Axillary Access</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  Need of a standard transvenous pacemaker or implantable cardioverter defibrillator&#xD;
             implantations&#xD;
&#xD;
          -  Age &gt; 18 years&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  Leadless pacemaker or subcutaneous ICD&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>120 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Matteo Bertini, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Universit√† degli Studi di Ferrara</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Matteo Bertini, MD, PhD</last_name>
    <phone>+39 532 236269</phone>
    <email>matteo.bertini@unife.it</email>
  </overall_contact>
  <verification_date>October 2021</verification_date>
  <study_first_submitted>October 20, 2021</study_first_submitted>
  <study_first_submitted_qc>October 20, 2021</study_first_submitted_qc>
  <study_first_posted type="Actual">November 1, 2021</study_first_posted>
  <last_update_submitted>October 20, 2021</last_update_submitted>
  <last_update_submitted_qc>October 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">November 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>University Hospital of Ferrara</investigator_affiliation>
    <investigator_full_name>Matteo Bertini</investigator_full_name>
    <investigator_title>MD, PhD, Professor</investigator_title>
  </responsible_party>
  <keyword>pacemaker</keyword>
  <keyword>ICD</keyword>
  <keyword>arrhythmias</keyword>
  <keyword>Cardiac Implantable Electronic Device</keyword>
  <keyword>Vascular access</keyword>
  <keyword>Venous puncture</keyword>
  <keyword>Ultrasound</keyword>
  <keyword>Fluoroscopy</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Arrhythmias, Cardiac</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

